Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 04 Jun 2024

Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy

in Cancer Immunity and Immunotherapy

Yeaseul Kim
Uksha Saini
Doyeon Kim
Ilse Hernandez-Aguirre
Jack Hedberg
Alexia Martin
Xiaokui Mo
Timothy P. Cripe
James Markert
Kevin A. Cassady

Frontiers in Immunology

doi 10.3389/fimmu.2024.1375413

3,427 views
2 citations

Correction

Published on 04 Jun 2024

Corrigendum: Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy

in Cancer Immunity and Immunotherapy

Yurong Qin
Miaozhe Huo
Xingwu Liu
Shuai Cheng Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1438587

723 views
5 citations

Original Research

Published on 03 Jun 2024

Establishment of a prognostic model for hypoxia-associated genes in OPSCC and revelation of intercellular crosstalk

in Cancer Immunity and Immunotherapy

Yichen Zhao
Jintao Yu
Chang Zheng
Baosen Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1371365

2,253 views
2 citations

Systematic Review

Published on 03 Jun 2024

Association of immune checkpoint inhibitors with SARS-CoV-2 infection rate and prognosis in patients with solid tumors: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Lin Sun
Fangmin Zhao
Yuying Xiang
Shuyi Chen
Qijin Shu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1259112

1,445 views

Editorial

Published on 03 Jun 2024

Editorial: Novel immunological characteristics and immunotherapeutic targets in pancreatic cancer

in Cancer Immunity and Immunotherapy

Husain Yar Khan
Yu Lou
Rachel E. Sexton-Bonacci

Frontiers in Immunology

doi 10.3389/fimmu.2024.1428740

1,207 views
1 citation

Systematic Review

Published on 03 Jun 2024

Prognostic value of tertiary lymphoid structures in hepatocellular carcinoma: a meta-analysis and systematic review

in Cancer Immunity and Immunotherapy

Lingbo Hu
Xuemei Li
Changhong Yang
Baoyong Zhou
Chengyou Du
Ning Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1390938

3,084 views
2 citations

Original Research

Published on 03 Jun 2024

Increased circulating polymorphonuclear myeloid-derived suppressor cells are associated with prognosis of metastatic castration-resistant prostate cancer

in Cancer Immunity and Immunotherapy

Takuro Kobayashi
Masayoshi Nagata
Tsuyoshi Hachiya
Haruhiko Wakita
Yoshihiro Ikehata
Keiji Takahashi
Toshiyuki China
Fumitaka Shimizu
Jun Lu
Yiming Jin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1372771

2,306 views
4 citations

Original Research

Published on 03 Jun 2024

Regulatory and memory T lymphocytes infiltrating prostate tumors predict long term clinical outcomes

in Cancer Immunity and Immunotherapy

Oscar Eduardo Molina
Hélène LaRue
David Simonyan
Hélène Hovington
Benjamin Vittrant
Bernard Têtu
Vincent Fradet
Louis Lacombe
Alain Bergeron
Yves Fradet

Frontiers in Immunology

doi 10.3389/fimmu.2024.1372837

2,025 views
3 citations

Review

Published on 03 Jun 2024

Fully equipped CARs to address tumor heterogeneity, enhance safety, and improve the functionality of cellular immunotherapies

in Cancer Immunity and Immunotherapy

Antonio Maria Alviano
Marta Biondi
Erica Grassenis
Andrea Biondi
Marta Serafini
Sarah Tettamanti

Frontiers in Immunology

doi 10.3389/fimmu.2024.1407992

24,940 views
3 citations

Original Research

Published on 31 May 2024

Expression and clinical significance of interleukin-6 pathway in cholangiocarcinoma

in Cancer Immunity and Immunotherapy

Dongqing Gu
Xin Zhao
Jing Song
Jianmei Xiao
Leida Zhang
Guohong Deng
Dajiang Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374967

2,191 views

Original Research

Published on 31 May 2024

Role of recombinant human granulocyte colony-stimulating factor in development of cancer-associated venous thromboembolism in lung cancer patients who undergo chemotherapy

in Cancer Immunity and Immunotherapy

Yi Cheng
Yunfeng Zhao
Mei Xu
He Du
Jinyuan Sun
Qihuan Yao
Jianmin Qu
Song Liu
Xuejun Guo
Wei Xiong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1386071

1,268 views

Review

Published on 31 May 2024

Tumor glucose metabolism and the T cell glycocalyx: implication for T cell function

in Cancer Immunity and Immunotherapy

Fabian Schuurmans
Kyra E. Wagemans
Gosse J. Adema
Lenneke A. M. Cornelissen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1409238

4,020 views
4 citations

Review

Published on 31 May 2024

From mechanism to therapy: the journey of CD24 in cancer

in Cancer Immunity and Immunotherapy

Kai Zhao
Caifeng Wu
Xiangjun Li
Mengchao Niu
Dan Wu
Xiaofeng Cui
Hai Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1401528

4,282 views
5 citations

Case Report

Published on 31 May 2024

Successful treatment with tislelizumab plus chemotherapy for SMARCA4-deficient undifferentiated tumor: a case report

in Cancer Immunity and Immunotherapy

Wen Dong
Anli Dai
Zhijun Wu
Jiangtao Wang
Tao Wu
Yangfeng Du
Wei Tian
Jiang Zheng
Yan Zhang
Hongming Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1371379

1,936 views
2 citations

Mini Review

Published on 31 May 2024

Unveiling the multifaceted antitumor effects of interleukin 33

in Cancer Immunity and Immunotherapy

Leire Arrizabalaga
Aline Risson
Miriam Ezcurra-Hualde
Fernando Aranda
Pedro Berraondo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1425282

2,639 views
5 citations

Editorial

Published on 30 May 2024

Editorial: Mathematical modeling and computational predictions in oncoimmunology

in Cancer Immunity and Immunotherapy

Vladimir A. Kuznetsov
Heiko Enderling
Mark Chaplain

Frontiers in Immunology

doi 10.3389/fimmu.2024.1432372

1,329 views
2 citations